| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |